Log on / register
Feedback | Support | My details

Comments

A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset™ or placebo

Richard E Scranton email, J Michael Gaziano email, Dean Rutty email, Michael Ezrokhi email and Anthony Cincotta email

BMC Endocrine Disorders 2007, 7:3doi:10.1186/1472-6823-7-3

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.